🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Types of surgical incision! #SoMe4IQLatAm #SoMe4Surgery #MedTwitter #GITwitter

Dr Jayapala Reddy Velagala Shailesh V. Shrikhande IHPBA Dr. Transplant Classical Joseph Type II (circumportal PD) with a Karasaki Type A (suprasplenic fusion) portal annular pancreas Had assisted a case in the unit with Shailesh V. Shrikhande Manish S Bhandare & Dr.Vikram Chaudhari. Brilliant video. Dr. Saneya has published on the topic.

🔥 npj Journals Precision Oncology 🆙 ✅Immunotherapy in lung cancer brain metastases 🎯The immune landscape of brain mets, emerging immunotherapeutic strategies, and promising biomarkers 🎙️Dr. Eunice Paisana #LCSM OncoAlert nature.com/articles/s4169…

I’m incredibly proud of the person you’ve become and the journey you’ve taken to get here. Your growth, dedication, and character speak volumes!

#DCRJournal Real World Question | Have you had been able to improve upon antibiotic stewardship for the treatment of uncomplicated diverticulitis at your institution? If so, how? Reply & let's discuss!

The CME-accredited Best of ASCO 2025 review series is coming to #Portland! Join Dr. Julie Graff and other leading experts at OHSU Knight Cancer Institute to break down the practice-changing abstracts from the 2025 ASCO® Annual Meeting. 🌟Register today: buff.ly/77Q2dmD #MedEd #MedTwitter

“ONCOSURG BHU 2025” : A Live Operative Surgical Oncology Training Workshop & CME Date: 5th July, 2025 Venue: S.S. Hospital, IMS, BHU, Varanasi, U.P. INDIA WHO SHOULD ATTEND: General Surgery residents, those interested in Surgical Oncology website: oncosurgbhu.in/index.php

Anatomically resectable versus biologically borderline resectable pancreatic cancer definition: refining the border beyond anatomical criteria and biological aggressiveness ➡️doi.org/10.1093/bjsope… Patients with biologically borderline resectable pancreatic cancer—an

Lower tumor regression grading enhances survival in gastric cancer. by Wu R, Lin S (...) Han L et 2 al. in Clin Transl Gastroenterol 🪡 read our summary 👉 stitches.today/2025/05/24/low…. 📖 read the article: journals.lww.com/ctg/abstract/9…

Complete pathological response of Primary .yToNo. Now what next? Chemo- for how long? Surveillance - MRI +?PET Ca 19.9 Role of ctDNA?? valuable opinion pl as this is 1st in our 350+ PD. @ihpba @eahpba @aphpba

🗓️ Next week on AIS: The future of learning! 🤖 May 28: Q&A with Dr. Julián Varas (Julian Varas, @facmedicinauc) on #AI for #SmartTraining! Ask live! 🔗 aischannel.com/coffee-with/ju… 📚 Plus, explore 1000s of hours of on-demand content anytime! #IamAIS #EdTech

Most viewed this week from JAMA Surgery: In acute care surgery, robotic-assisted cholecystectomy and laparoscopic cholecystectomy had comparable rates of bile duct injury but differences in secondary outcomes ja.ma/44RdVk1

Rare but Real: Portal Annular Pancreas (PAP) poses unique surgical challenges during Whipples - AIG Hospitals' Department of Surgical Gastroenterology Click doi.org/10.14701/ahbps… to read the full article. #WhippleProcedure #AIGHospitals #GISurgery #Pancreatoduodenectomy

C-reactive protein-to-albumin ratio predicts outcome of neoadjuvant chemotherapy for colorectal liver metastases: A multicenter prediction model ⁦SURGERY Journal⁩ surgjournal.com/article/S0039-…

JAMA Surgery Supports other studies showing higher rate of complications or BDI with 🤖. I don’t understand why 🤖in routine GB when lap is generalizable, safe, & MIS. I understand why people are keen on 🤖for big operations as it enables MIS. It just adds cost and risk for gallbladder. 🤷🏽‍♂️

Molecular prognostic factors for liver transplantation of unresectablemetastatic colorectal cancer ➡️doi.org/10.1093/bjs/zn… Mutations in 20 CRC-relevant genes and transcriptomic profiles of liver metastases from 34 patients included in prospective trials of LT for

🔥Localised rectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up🔥 Annals of Oncology doi.org/10.1016/j.anno… 👉Important updates on the treatment of rectal cancer 👉Multiple options and strategies ESMO - Eur. Oncology

BBR (Biologically Borderline Resectable) PDAC: CA19-9 ≥200 U/ml at 26–28d, symptoms >40d, and/or radiological/cytological lymph node metastases. #PancreaticCancer #research

✂️ Arterial resection and divestment 🔟 year comparative study 🇯🇵 Analysis of 200 PDAC + artery 👗 Divestment (120 cases) most used in first 5 years 🎖️Last 5 years ⬆️ Neoadjuvant chemo + resection ⬇️ complications 👍 academic.oup.com/bjsopen/articl…

Periarterial divestment for borderline and locally advanced pancreatic cancer: An analysis of 125 cases in a single center - SURGERY Journal surgjournal.com/article/S0039-…